Editorial: Simplifying Screening for Primary Liver Cancer - Do the LCR1 and LCR2 Tests Hold the Key?
Overview
Overview
Journal
Aliment Pharmacol Ther
Specialties
Gastroenterology
Pharmacology
Pharmacology
Date
2019 Feb 13
PMID
30746772
Citations
1
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Yu C, Sun C Evid Based Complement Alternat Med. 2022; 2022:6581127.
PMID: 35711497 PMC: 9197641. DOI: 10.1155/2022/6581127.
References
1.
Bird T, Dimitropoulou P, Turner R, Jenks S, Cusack P, Hey S
. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection. PLoS One. 2016; 11(6):e0156801.
PMC: 4911090.
DOI: 10.1371/journal.pone.0156801.
View
2.
Tayob N, Lok A, Do K, Feng Z
. Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. Clin Gastroenterol Hepatol. 2015; 14(3):469-475.e2.
PMC: 4744807.
DOI: 10.1016/j.cgh.2015.07.049.
View
3.
Johnson P, Pirrie S, Cox T, Berhane S, Teng M, Palmer D
. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiol Biomarkers Prev. 2013; 23(1):144-53.
DOI: 10.1158/1055-9965.EPI-13-0870.
View
4.
Berhane S, Toyoda H, Tada T, Kumada T, Kagebayashi C, Satomura S
. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. Clin Gastroenterol Hepatol. 2016; 14(6):875-886.e6.
DOI: 10.1016/j.cgh.2015.12.042.
View
5.
Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W
. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®). J Hepatol. 2013; 60(4):706-14.
DOI: 10.1016/j.jhep.2013.11.016.
View